Skip to main content

06-11-2016 | Advanced breast cancer | Article

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2–Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study

Perez EA et al. J Clin Oncol 2017; 35(2): 141-148. doi:10.1200/JCO.2016.67.4887

Please log in to get access to this content

Related topics